ALXN Dividend History & Description — Alexion Pharmaceuticals Inc.
Alexion Pharmaceuticals is a biopharmaceutical company serving patients and families affected by rare diseases through the discovery, development and commercialization of therapies. Co. has developed and commercializes two complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, as well as the complement inhibitor to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis and neuromyelitis optica spectrum disorder in patients who are anti-aquaporin-4 antibody positive. Co. also has two enzyme replacement therapies for metabolic disorders, hypophosphatasia and lysosomal acid lipase deficiency. When considering the Alexion Pharmaceuticals Inc. stock dividend history, we have taken known splits into account, such that the ALXN dividend history is presented on a split-adjusted ("apples to apples") basis. Alexion Pharmaceuticals Inc. dividend history is presented both in graphical/chart form, and as a ALXN dividend history data table along the right-hand column.